| Literature DB >> 22624709 |
Abstract
CD37 is a tetraspannin that triggers cell death and is a potential therapeutic target in cancers. In this issue of Cancer Cell, Lapalombella et al. show that CD37 is tyrosine phosphorylated following engagement by a bivalent engineered antibody fragment that binds CD37 and activates both SHP-1-dependent apoptotic signaling and PI3K-AKT-mediated survival signaling.Entities:
Year: 2012 PMID: 22624709 PMCID: PMC4363110 DOI: 10.1016/j.ccr.2012.04.034
Source DB: PubMed Journal: Cancer Cell ISSN: 1535-6108 Impact factor: 31.743